Head-to-head · WeighScore
Kongo vs LumiMeds
The verdict
Kongo takes it — 83.8/100 to 63.2/100.
Kongo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cheap semaglutide ($119) but a steeper tirzepatide step-up ($229); verified, nationwide.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Kongo | LumiMeds |
|---|---|---|
| WeighScore | 83.8/100 | 63.2/100 |
| Grade | B | C |
| Scorecard rank | #21 | #284 |
| Semaglutide | $119/mo | $133/mo (starting dose, compounded) |
| Tirzepatide | $229/mo | $133/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #21 · B
Strengths
- $119 semaglutide
- All 50 states, LegitScript-verified
- Both molecules
Where it loses points
- Tirzepatide jumps to $229/mo
- Injection-only
- Monitoring detail sparse
Graded #284 · C
FDAWarning letter issued to Lumimeds in September 2025. See the FDA warning-letter database.
Strengths
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Where it loses points
- Limited public information on program details
- FDA issued Lumimeds a warning letter in September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.